Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Tecovirimat-d4

Tecovirimat-d4 (ST-246-d4) is a deuterium-labelled Tecovirimat. Tecovirimat is an orally bioavailable and selective compound against orthopoxviruses [including vaccinia, monkeypox, camelpox, cowpox, ectromelia (mousepox), smallpox and variola viruses]. Tecovirimat is evaluated against vaccinia, cowpox virus, ectromelia virus with EC50 values of 0.01 μM, 0.48 μM and 0.05 μM, respectively. Tecovirimat targets the orthopoxvirus protein VP37 which is necessary for membrane envelopment of intracellular mature virus particles to form enveloped virus. Tecovirimat exerts antiviral activity on the target of the cowpox virus V061 gene, which is homologous to vaccinia virus F13L, encoding a major envelope protein (p37) required for production of extracellular virus. Tecovirimat could be used in the study for orthopoxvirus-induced diseases[1][2][3][4][5].

Product Specifications

Product Name Alternative

ST-246-d4

UNSPSC

12352005

Target

Arenavirus; Isotope-Labeled Compounds; Orthopoxvirus

Type

Isotope-Labeled Compounds

Related Pathways

Anti-infection; Others

Field of Research

Infection

Purity

98.95

Solubility

10 mM in DMSO|DMSO : 100mg/mL (ultrasonic)

Smiles

O=C(NN(C([C@]1([H])[C@@]2([H])[C@@](C3)([H])[C@@]3([H])[C@@](C=C2)([H])[C@]41[H])=O)C4=O)C5=C([2H])C([2H])=C(C(F)(F)F)C([2H])=C5[2H]

Molecular Formula

C19H11D4F3N2O3

Molecular Weight

380.35

References & Citations

[1]Yang G, et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge. J Virol. 2005 Oct;79 (20) :13139-49. |[2]Quenelle DC, et al. Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice. Antimicrob Agents Chemother. 2007 Feb;51 (2) :689-95.|[3]Andrew T Russo, et al. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther. 2021 Mar;19 (3) :331-344.|[4]DeLaurentis CE, et al. New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus[J]. Antimicrob Agents Chemother. 2022 Dec 20;66 (12) :e0122622. |[5]Almehmadi M, et al. A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak[J]. Viruses. 2022 Aug 25;14 (9) :1870.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Rabbit Polyclonal CARD12 Antibody [Dylight 755]
NBP1-78980IR 0.1 mL

Rabbit Polyclonal CARD12 Antibody [Dylight 755]

Sign In for Pricing
View Details
CD326 Rat Monoclonal Antibody
orb2988604-01 30 µL

CD326 Rat Monoclonal Antibody

Sign In for Pricing
View Details
CD326 Rat Monoclonal Antibody
orb2988604-02 50 µL

CD326 Rat Monoclonal Antibody

Sign In for Pricing
View Details
CD326 Rat Monoclonal Antibody
orb2988604-03 100 µL

CD326 Rat Monoclonal Antibody

Sign In for Pricing
View Details
CD326 Rat Monoclonal Antibody
orb2988604-04 200 µL

CD326 Rat Monoclonal Antibody

Sign In for Pricing
View Details
RNF6 Antibody
orb680908 100 µL

RNF6 Antibody

Sign In for Pricing
View Details